稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常临床效果研究

Clinical study on the effect of Wenxin Granule Combined with amiodarone in the treatment of atrial fibrillation and frequent ventricular arrhythmias

目的:探讨稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常患者的临床疗效。方法:2012年1月-2014年1月收治房颤合并频发室性心律失常患者60例,随机分为观察组和对照组,对照组单用胺碘酮治疗,观察组加用稳心颗粒治疗,并比较两组疗效。结果:观察组的总有效率(90.0%)明显大于对照组(76.7%),长间期发生率(6.67%)明显小于对照组(26.7%),且P<0.05。结论:稳心颗粒联合胺碘酮治疗房颤合并频发室性心律失常患者可明显提高疗效,并降低长RR间期的发生率,值得临床推广。

Objective:To explore the clinical curative effect of Wenxin Granule Combined with amiodarone in the treatment of atrial fibrillation and frequent ventricular arrhythmias.Methods:We selected 60 cases of atrial fibrillation and ventricular arrhythmia patients in January 2012 to January 2014.These patients were randomly divided into observation group and control group.Control group was treated with amiodarone,while observation group added Wenxin Granule.The treatment effect of the two groups were compared.Results:In the observation group,the total efficiency(90.0%) was obviously higher than that of control group(76.7%),and long interval incidence(6.67%) was significantly lower than that of control group(26.7%), P<0.05.Conclusion: The effect of Wenxin Granule Combined with amiodarone in the treatment of atrial fibrillation and frequent ventricular arrhythmias is significant.It can reduce the incidence of long RR interval.So it is worth the clinical promotion.